SeQuent Scientific Ltd SEQUENT-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 3:26 PM IST
290.00quote price arrow down-2.55 (-0.87%)
Volume
449,255
52 week range
73.25 - 312.00

...

Loading . . .
  • Open292.55
  • Day High294.90
  • Day Low288.25
  • Prev Close292.55
  • 52 Week High312.00
  • 52 Week High Date04/30/21
  • 52 Week Low73.25
  • 52 Week Low Date05/04/20

Key Stats

  • Market Cap966.73M
  • Shares Out245M
  • 10 Day Average Volume1.1M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change70.89

KEY STATS

  • Open292.55
  • Day High294.90
  • Day Low288.25
  • Prev Close292.55
  • 52 Week High312.00
  • 52 Week High Date04/30/21
  • 52 Week Low73.25
  • 52 Week Low Date05/04/20
  • Market Cap966.73M
  • Shares Out245M
  • 10 Day Average Volume1.1M
  • Dividend-
  • Dividend Yield-
  • Beta
  • YTD % Change70.89

RATIOS/PROFITABILITY

  • EPS (TTM)3.92
  • P/E (TTM)73.95
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date08/21/2019
  • Div Amount0.20
  • Split Date-
  • Split Factor-

Latest On SeQuent Scientific Ltd

There is no recent news for this security.

Latest From Our Partners

There is no recent news for this security.

Profile

MORE
SeQuent Scientific Limited is an India-based integrated pharmaceutical company. The Company operates in the domains of animal health and analytical services. The animal health business, Alivira, includes active pharmaceutical ingredient and finished dosage formulations. Its therapies targeted are anthelmintics (endo and ecto parasiticides), anti-protozoals, nutraceuticals, nonsteroidal anti-inflammatory drugs (NSAID), anti-infectives and dermatology. The Company’s analytical...
Manish Gupta
Chief Executive Officer
Tushar Mistry
Chief Financial Officer
Address
120 A & B, Industrial area, Baikampady
Bangalore
560078
India